Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from a consumer via SPMSD (case reported number DE-1577272925-2016007325) on 18-JUL-2016. Case received on 12-Jul-2016. A 15-year-old female adolescent patient received GARDASIL (lot and batch number K009460, Dose 1, expiry date: Sep 2016) on 31-Mar-2015, GARDASIL (lot and batch number K022803, dose 2, expiry date: Nov 2016) on 03-Jun-2015. The patient experienced epilepsy on April 2015. Starting in April 2015, first petit mal occurred. Starting in September 2015, worsening to grand mal. Meanwhile manifest epilepsy was diagnosed. The patient had a medical history of febrile seizure and received Pertussis vaccine. The patient''s outcome was reported as Not Recovered/Not Resolved. The reporter assessed the causal relationship between epilepsy and GARDASIL as unknown. The rechallenge result is positive.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166